Darrell Carney
Amministratore Delegato presso Chrysalis BioTherapeutics, Inc.
Profilo
Darrell H.
Carney is the founder of Chrysalis BioTherapeutics, Inc. and held the titles of Chairman, President & Chief Executive Officer.
Posizioni attive di Darrell Carney
Società | Posizione | Inizio |
---|---|---|
Chrysalis BioTherapeutics, Inc.
Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Chrysalis BioTherapeutics, Inc.
Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Health Technology |
- Borsa valori
- Insiders
- Darrell Carney